Back to User profile » Dr Keiji Hirai
Papers published by Dr Keiji Hirai:
Prevalence of Significant Coronary Artery Stenosis and Relationship with Carotid Maximum Intima-Media Thickness in Asymptomatic Patients with Moderate-to-Severe Chronic Kidney Disease: A Single-Center, Prospective, Cross-Sectional Study
Hirai K, Shibata H, Shizukuishi K, Hatori M, Taniguchi Y, Ugata Y, Jinnouchi H, Ito K, Watanabe T, Onoguchi A, Watano T, Manabe O, Sakakura K, Ookawara S, Omoto K, Oyama-Manabe N, Fujita H, Morishita Y
Vascular Health and Risk Management 2025, 21:1079-1091
Published Date: 15 December 2025
Efficacy and Safety of Adding Empagliflozin to Liraglutide on Renal Function in Patients with Advanced-Stage Type 2 Diabetic Kidney Disease: A Randomized Controlled Trial
Sunagawa K, Hirai K, Sunagawa S, Kamiya N, Komesu I, Sunagawa Y, Sunagawa H, Nakachi K, Hirai A, Ookawara S, Morishita Y
Diabetes, Metabolic Syndrome and Obesity 2024, 17:3767-3781
Published Date: 14 October 2024
Anti-SARS-CoV-2 Spike Antibody Response to the Fourth Dose of BNT162b2 mRNA COVID-19 Vaccine and Associated Factors in Japanese Hemodialysis Patients
Hirai K, Shimotashiro M, Okumura T, Ookawara S, Morishita Y
International Journal of Nephrology and Renovascular Disease 2024, 17:135-149
Published Date: 17 May 2024
The Efficacy and Safety of Dotinurad on Uric Acid and Renal Function in Patients with Hyperuricemia and Advanced Chronic Kidney Disease: A Single Center, Retrospective Analysis
Yanai K, Hirai K, Kaneko S, Mutsuyoshi Y, Kitano T, Miyazawa H, Ito K, Ueda Y, Ookawara S, Morishita Y
Drug Design, Development and Therapy 2023, 17:3233-3248
Published Date: 3 November 2023
No Significant Changes of Glycemic Control and Renal Function in Patients with Advanced-Stage Diabetic Kidney Disease by Switching from Linagliptin to Teneligliptin
Hirai K, Nonaka H, Ueda M, Morino J, Kaneko S, Minato S, Mutsuyoshi Y, Yanai K, Ishii H, Matsuyama M, Kitano T, Aomatsu A, Miyazawa H, Ito K, Ueda Y, Ookawara S, Morishita Y
Pragmatic and Observational Research 2021, 12:81-91
Published Date: 6 August 2021
Factors Associated with the Change in Carotid Maximum Intima-Media Thickness in Patients with Moderate-to-Advanced Stage Chronic Kidney Disease
Hirai K, Morino J, Minato S, Kaneko S, Yanai K, Mutsuyoshi Y, Ishii H, Matsuyama M, Kitano T, Aomatsu A, Miyazawa H, Ito K, Ueda Y, Ookawara S, Morishita Y
Diabetes, Metabolic Syndrome and Obesity 2020, 13:3637-3643
Published Date: 12 October 2020
The Efficacy and Safety of Sodium-Glucose Cotransporter-2 Inhibitors in Patients with Advanced-Stage Diabetic Kidney Disease Taking Renin-Angiotensin System Blockers
Hirai K, Morino J, Minato S, Kaneko S, Yanai K, Mutsuyoshi Y, Ishii H, Matsuyama M, Kitano T, Shindo M, Aomatsu A, Miyazawa H, Ito K, Ueda Y, Ookawara S, Morishita Y
Diabetes, Metabolic Syndrome and Obesity 2020, 13:215-225
Published Date: 30 January 2020
Factors Associated with Uremic Pruritus in Patients Undergoing Peritoneal Dialysis
Minato S, Hirai K, Morino J, Kaneko S, Yanai K, Mutsuyoshi Y, Ishii H, Matsuyama M, Kitano T, Shindo M, Aomatsu A, Miyazawa H, Ito K, Ueda Y, Hoshino T, Ookawara S, Morishita Y
International Journal of Nephrology and Renovascular Disease 2020, 13:1-9
Published Date: 14 January 2020
Risk factors and utility of maximum carotid intima–media thickness as a surrogate marker for coronary artery stenosis
Hirai K, Imamura S, Hirai A, Misumi K, Ookawara S, Morishita Y
Therapeutics and Clinical Risk Management 2018, 14:1407-1416
Published Date: 13 August 2018